224 related articles for article (PubMed ID: 35831020)
1. Liver steatosis and metabolic dysfunction-associated fatty liver disease among HIV-positive and negative adults in urban Zambia.
Chihota BV; Riebensahm C; Muula G; Sinkala E; Chilengi R; Mulenga L; Bosomprah S; Vinikoor MJ; Bolton-Moore C; Egger M; Rauch A; Berzigotti A; Wandeler G;
BMJ Open Gastroenterol; 2022 Jul; 9(1):. PubMed ID: 35831020
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome among treatment-naïve people living with and without HIV in Zambia and Zimbabwe: a cross-sectional analysis.
Chihota BV; Mandiriri A; Shamu T; Muula G; Nyamutowa H; Taderera C; Mwamba D; Chilengi R; Bolton-Moore C; Bosomprah S; Egger M; Chimbetete C; Wandeler G;
J Int AIDS Soc; 2022 Dec; 25(12):e26047. PubMed ID: 36522287
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy.
Perazzo H; Cardoso SW; Yanavich C; Nunes EP; Morata M; Gorni N; da Silva PS; Cardoso C; Almeida C; Luz P; Veloso VG; Grinsztejn B
J Int AIDS Soc; 2018 Nov; 21(11):e25201. PubMed ID: 30394678
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.
Jongraksak T; Sobhonslidsuk A; Jatchavala J; Warodomwichit D; Kaewduang P; Sungkanuparph S
Int J STD AIDS; 2021 Mar; 32(3):266-275. PubMed ID: 33334267
[TBL] [Abstract][Full Text] [Related]
5. Metabolic dysfunction-associated fatty liver disease in people living with HIV.
Michel M; Labenz C; Armandi A; Kaps L; Kremer WM; Galle PR; Grimm D; Sprinzl M; Schattenberg JM
Sci Rep; 2023 Jun; 13(1):9158. PubMed ID: 37280241
[TBL] [Abstract][Full Text] [Related]
6. Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort.
Arenas-Pinto A; Bakewell N; Milinkovic A; Williams I; Vera J; Post FA; Anderson J; Beynon M; O'Brien A; Doyle N; Gilson R; Pett SL; Winston A; Sabin CA;
HIV Med; 2024 Jan; 25(1):95-106. PubMed ID: 37670375
[TBL] [Abstract][Full Text] [Related]
7. Impact of the new definition of metabolic dysfunction-associated fatty liver disease on detection of significant liver fibrosis in US adolescents.
Ciardullo S; Carbone M; Invernizzi P; Perseghin G
Hepatol Commun; 2022 Aug; 6(8):2070-2078. PubMed ID: 35470984
[TBL] [Abstract][Full Text] [Related]
8. Metabolic causes of liver disease among adults living with HIV from low- and middle-income countries: a cross-sectional study.
Plaisy MK; Minga AK; Wandeler G; Murenzi G; Samala N; Ross J; Lopez A; Mensah E; de Waal R; Kuniholm MH; Diero L; Salvi S; Moreira R; Attia A; Mandiriri A; Shumbusho F; Goodrich S; Rupasinghe D; Alarcon P; Maruri F; Perrazo H; Jaquet A;
J Int AIDS Soc; 2024 Apr; 27(4):e26238. PubMed ID: 38566493
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy.
Riebensahm C; Berzigotti A; Surial B; Günthard HF; Tarr PE; Furrer H; Rauch A; Wandeler G;
Open Forum Infect Dis; 2022 Nov; 9(11):ofac538. PubMed ID: 36381613
[TBL] [Abstract][Full Text] [Related]
10. Liver Steatosis is Prevalent in Lean People With HIV and Associated With Exposure to Antiretroviral Treatment-A Cross-sectional Study.
van Eekeren LE; Vadaq N; Vos WAJW; Blaauw MJT; Groenendijk AL; van Lunzen J; Stalenhoef JE; Berrevoets MAH; Verbon A; Weijers G; Netea MG; van der Ven AJAM; de Mast Q; Joosten LAB; Tjwa ETTL
Open Forum Infect Dis; 2024 Jun; 11(6):ofae266. PubMed ID: 38868310
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: Decreased Physical Activity and Prolonged Sitting Time Are Associated With Liver Steatosis in People With HIV.
Riebensahm C; Berzigotti A; Surial B; Haerry D; Günthard HF; Tarr PE; Furrer H; Rauch A; Wandeler G;
J Acquir Immune Defic Syndr; 2024 Feb; 95(2):179-184. PubMed ID: 37988659
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway.
Sebastiani G; Milic J; Gioe C; Al Hinai AS; Cervo A; Lebouche B; Deschenes M; Cascio A; Mazzola G; Guaraldi G
Lancet HIV; 2022 Mar; 9 Suppl 1():S4. PubMed ID: 35304846
[TBL] [Abstract][Full Text] [Related]
14. High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease.
Zhu C; Huang D; Ma H; Qian C; You H; Bu L; Qu S
Front Endocrinol (Lausanne); 2022; 13():848937. PubMed ID: 35620390
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
[TBL] [Abstract][Full Text] [Related]
16. Metabolic dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia.
Wong WK; Chan WK; Ganapathy SS; Lim SK
Semin Dial; 2023 Mar; 36(2):107-116. PubMed ID: 35821201
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in Zambian adults with human immunodeficiency virus on antiretroviral therapy: Prevalence and associated factors.
Hamooya BM; Mulenga LB; Masenga SK; Fwemba I; Chirwa L; Siwingwa M; Halwiindi H; Koethe JR; Lipworth L; Heimburger DC; Musonda P; Mutale W
Medicine (Baltimore); 2021 Apr; 100(14):e25236. PubMed ID: 33832083
[TBL] [Abstract][Full Text] [Related]
18. Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease.
Lee CH; Lui DT; Li RH; Yuen MM; Fong CH; Leung AP; Chu JC; Mak LL; Lam TH; Woo J; Woo YC; Xu A; Tse HF; Tan KC; Cheung BM; Yuen MF; Lam KS
Front Endocrinol (Lausanne); 2022; 13():1056562. PubMed ID: 36686469
[TBL] [Abstract][Full Text] [Related]
19. Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.
Vinikoor MJ; Sinkala E; Mweemba A; Zanolini A; Mulenga L; Sikazwe I; Fried MW; Eron JJ; Wandeler G; Chi BH
Liver Int; 2015 Jul; 35(7):1886-92. PubMed ID: 25581487
[TBL] [Abstract][Full Text] [Related]
20. Metabolic dysfunction-associated fatty liver disease and liver fibrosis: Prevalence and associated factors in the middle-aged and older US population.
Yang S; Cheng J; Zhang R; Sun H; Zhang H; Lyu S; Duan W
Hepatol Res; 2022 Feb; 52(2):176-186. PubMed ID: 34751487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
